U.S. markets closed
  • S&P Futures

    +5.00 (+0.15%)
  • Dow Futures

    +42.00 (+0.15%)
  • Nasdaq Futures

    +11.25 (+0.10%)
  • Russell 2000 Futures

    +3.30 (+0.22%)
  • Crude Oil

    -0.28 (-0.71%)
  • Gold

    -1.80 (-0.09%)
  • Silver

    -0.07 (-0.29%)

    +0.0006 (+0.05%)
  • 10-Yr Bond

    -0.0180 (-2.71%)
  • Vix

    +0.08 (+0.31%)

    +0.0009 (+0.07%)

    +0.0450 (+0.04%)

    +126.78 (+1.18%)
  • CMC Crypto 200

    -6.70 (-2.92%)
  • FTSE 100

    -30.43 (-0.51%)
  • Nikkei 225

    -27.96 (-0.12%)

Archer Daniels' (ADM) Stock Up on Q2 Earnings & Sales Beat

Zacks Equity Research

Shares of Archer Daniels Midland Company ADM increased 1.6% after the close of the trading session on Jul 29, following its robust second-quarter 2020 results. Amid the ongoing COVID-19 crisis, the company remains committed to improving its underperforming categories, driving Readiness and investing primarily in the Nutrition unit.

Adjusted earnings of 85 cents per share rose 41.7% from the year-ago quarter and outpaced the Zacks Consensus Estimate of 51 cents. On a reported basis, the company’s earnings were 84 cents per share, up two-folds from the prior-year quarter’s 42 cents.

Revenues declined 0.1% year over year to $16,281 million but exceeded the Zacks Consensus Estimate of $15,401 million. Robust sales growth in the Nutrition and the Ag Services & Oilseeds segments provided some cushion to the top line.

Gross profit grew 14% year over year to $1,108 million, while gross margin expanded 80 basis points (bps) to 6.8% in the quarter under review. Also, SG&A expenses rose 6% to $638 million.

Archer Daniels Midland Company Price, Consensus and EPS Surprise

Archer Daniels Midland Company Price, Consensus and EPS Surprise
Archer Daniels Midland Company Price, Consensus and EPS Surprise

Archer Daniels Midland Company price-consensus-eps-surprise-chart | Archer Daniels Midland Company Quote

Operational Discussion

Segment-wise, revenues for the Nutrition and the Ag Services & Oilseeds segments advanced 5.7% and 4.2% year over year to $1,471 million and $12,741 million, respectively. Meanwhile, revenues for the Carbohydrate Solutions segment were $2,014 million, reflecting a decline of 16.4% year over year.

Moreover, Archer Daniels reported adjusted segment operating profit of $804 million in second-quarter 2020, up 17.9% from the year-ago quarter. On a GAAP basis, the company’s segmental operating profits improved nearly 26% year over year to $813 million.

Adjusted operating profit at Ag Services & Oilseeds increased 14% year over year to $413 million. Operating results gained from solid performance in South America that led to higher volumes and improved margins stemming from softness in Brazil Real and strong farmer selling. On the flip side, dismal margins in interior grain affected North America.

Despite higher year-over-year growth in South America, driven by strong demand in domestic meal and soft Brazilian Real along with robust crush volumes and margins in EMEAI, the crushing business was a drab year over year. Additionally, North America witnessed weak margins due to COVID-19 impacts.

Operating results for Refined Products and Other improved year over year, driven by solid margins and volumes in biodiesel in North and South America as well as sturdy volumes and margins in refined and packaged oils in South America, somewhat offset by lower biodiesel margins in EMEAI.

The Carbohydrate Solutions segment’s adjusted operating profit fell 1.6% to $195 million due to a soft performance by Starches and Sweeteners resulting from lesser demand for foodservice in North America along with loss of corn oil contracts. However, the unit gained from reduced raw-material expenses and risk control measures. Meanwhile, Vantage Corn Processors performed well year over year on the back of solid demand for industrial ethanol and improved inventory level.

In the Nutrition segment, adjusted operating profit of $158 million rallied 35% from $117 million in the year-ago quarter owing to significant gains in Human and Animal Nutrition units. The Human Nutrition division gained from its diversified portfolio and higher sales of North America flavors. The Animal Nutrition unit retained growth in the quarter under review, driven by a solid performance from Neovia, strong demand for amino acids and sturdy sales in pet care.

Other Financials

Archer Daniels ended the quarter with cash and cash equivalents of $1,203 million, long-term debt, including current maturities, of $8,642 million, and shareholders’ equity of $19,311 million.

During the quarter, the company used $436 million in cash for operating activities. Additionally, it bought back shares of $112 million and paid out dividends of $405 million in the reported quarter.

Price Performance

In the past three months, shares of this Zacks Rank #3 (Hold) company have gained 15.6% compared with the industry’s 10.7% growth.

Stocks to Consider

Helen of Troy HELE has a long-term earnings growth rate of 6.5% and a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Clorox Company CLX has a long-term earnings growth rate of 5.9%. The stock presently carries a Zacks Rank #2 (Buy).

The Kraft Heinz Company KHC, with a long-term earnings growth rate of 6%, currently carries a Zacks Rank #2.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Archer Daniels Midland Company (ADM) : Free Stock Analysis Report
The Clorox Company (CLX) : Free Stock Analysis Report
Helen of Troy Limited (HELE) : Free Stock Analysis Report
The Kraft Heinz Company (KHC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research